LifeStance Health Group, Inc. LFST
$12.52
-$0.10-0.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.38% | 16.46% | 13.85% | 13.39% | 13.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.38% | 16.46% | 13.85% | 13.39% | 13.86% |
| Cost of Revenue | 18.53% | 16.34% | 13.51% | 11.27% | 10.47% |
| Gross Profit | 24.24% | 16.71% | 14.59% | 18.06% | 21.60% |
| SG&A Expenses | 7.61% | 5.70% | 5.91% | 8.16% | 5.58% |
| Depreciation & Amortization | -5.20% | -12.60% | -22.83% | -28.67% | -30.67% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.42% | 11.93% | 9.35% | 7.91% | 6.32% |
| Operating Income | 10,223.28% | 479.60% | 181.87% | 114.24% | 100.95% |
| Income Before Tax | 409.15% | 187.60% | 121.46% | 86.54% | 86.43% |
| Income Tax Expenses | 397.01% | 483.33% | 1,688.24% | -131.55% | 36.73% |
| Earnings from Continuing Operations | 413.29% | 165.09% | 116.82% | 90.43% | 89.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 413.29% | 165.09% | 116.82% | 90.43% | 89.30% |
| EBIT | 10,223.28% | 479.60% | 181.87% | 114.24% | 100.95% |
| EBITDA | 129.68% | 97.11% | 90.00% | 160.48% | 3,113.06% |
| EPS Basic | 409.67% | 163.79% | 116.40% | 90.65% | 89.53% |
| Normalized Basic EPS | 435.74% | 193.72% | 121.40% | 86.13% | 80.88% |
| EPS Diluted | 367.29% | 159.34% | 114.93% | 90.33% | 88.19% |
| Normalized Diluted EPS | 430.33% | 191.51% | 120.65% | 86.05% | 80.88% |
| Average Basic Shares Outstanding | 0.91% | 1.61% | 1.81% | 2.25% | 2.35% |
| Average Diluted Shares Outstanding | 1.89% | 2.34% | 3.02% | 2.87% | 2.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |